Literature DB >> 15809299

Cell surface expression of 5-hydroxytryptamine type 3 receptors is promoted by RIC-3.

Aixin Cheng1, Neil A McDonald, Christopher N Connolly.   

Abstract

RIC-3 has been identified as a molecule essential for the recruitment of functional nicotinic acetylcholine receptors composed of alpha7, but it exhibits inhibitory effects on alpha4beta2 or alpha3beta4 receptors. In this study, we investigated the role of RIC-3 in the recruitment of 5-hydroxytryptamine type 3A (5-HT(3A)) receptors to the cell surface. Although RIC-3 is not essential for the surface transport of 5-HT(3A) receptors, we found that its presence enhances both receptor transport and function in a concentration-dependent manner. RIC-3 is localized to the endoplasmic reticulum, as evidenced by co-localization with the chaperone molecule, binding protein (BiP). RIC-3 is not detected at significant levels on the cell surface when expressed alone or in the presence of 5-HT(3A). RIC-3 and 5-HT(3A) show a low level interaction that is transient (<4 h). That RIC-3 can interact with an endoplasmic reticulum-retained 5-HT(3A) construct, combined with the transient interaction observed and lack of significant surface-expressed RIC-3, suggests that RIC-3 may play a role in 5-HT(3A) receptor folding, assembly, or transport to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809299     DOI: 10.1074/jbc.M414341200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The conserved RIC-3 coiled-coil domain mediates receptor-specific interactions with nicotinic acetylcholine receptors.

Authors:  Yoav Biala; Jana F Liewald; Hagit Cohen Ben-Ami; Alexander Gottschalk; Millet Treinin
Journal:  Mol Biol Cell       Date:  2008-12-30       Impact factor: 4.138

2.  Two neuronal nicotinic acetylcholine receptors, alpha4beta4 and alpha7, show differential agonist binding modes.

Authors:  Nyssa L Puskar; Xinan Xiu; Henry A Lester; Dennis A Dougherty
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

3.  Delineating the Site of Interaction of the 5-HT3A Receptor with the Chaperone Protein RIC-3.

Authors:  Elham Pirayesh; Antonia G Stuebler; Akash Pandhare; Michaela Jansen
Journal:  Biophys J       Date:  2019-11-28       Impact factor: 4.033

4.  Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.

Authors:  Sita Nirupama Nishtala; Nelli Mnatsakanyan; Akash Pandhare; Chun Leung; Michaela Jansen
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

5.  Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites.

Authors:  John K Alexander; Daphna Sagher; Arcadius V Krivoshein; Manuel Criado; Gregory Jefford; William N Green
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

Review 6.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

7.  An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.

Authors:  Christopher B Marotta; Henry A Lester; Dennis A Dougherty
Journal:  Chem Biol       Date:  2015-07-23

8.  Muscle-like nicotinic receptor accessory molecules in sensory hair cells of the inner ear.

Authors:  Abdullah A Osman; Angela D Schrader; Aubrey J Hawkes; Omar Akil; Adam Bergeron; Lawrence R Lustig; Dwayne D Simmons
Journal:  Mol Cell Neurosci       Date:  2008-03-04       Impact factor: 4.314

Review 9.  RIC-3: a nicotinic acetylcholine receptor chaperone.

Authors:  N S Millar
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

10.  A New Mechanism of Receptor Targeting by Interaction between Two Classes of Ligand-Gated Ion Channels.

Authors:  Michel Boris Emerit; Camille Baranowski; Jorge Diaz; Audrey Martinez; Julie Areias; Jeanine Alterio; Justine Masson; Eric Boué-Grabot; Michèle Darmon
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.